Search research articles
Contact Us
Filters
Showing results (91-100 of 222) with videos related to
Page
of 23
Sort By:
Pharmacological Reviews
|
March 8, 2017
International Union of Basic and Clinical Pharmacology. C. Nomenclature and Properties of Calcium-Activated and Sodium-Activated Potassium Channels
Leonard K Kaczmarek, Richard W Aldrich, K George Chandy, et al.
Molecular Pharmacology
|
May 25, 2004
Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators
Julia Vennekamp, Heike Wulff, Christine Beeton, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 23, 2012
Structure-activity relationship exploration of Kv1.3 blockers based on diphenoxylate
William Nguyen, Brittany L Howard, David P Jenkins, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 19, 2010
Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis
Lie Di, Shekhar Srivastava, Olga Zhdanova, et al.
Frontiers in Pharmacology
|
June 12, 2012
Triarylmethanes, a new class of cx50 inhibitors
Silke B Bodendiek, Clio Rubinos, Maria Pilar Trelles, et al.
Physiological Reports
|
May 15, 2018
Alpha<sub>1</sub> -adrenergic stimulation selectively enhances endothelium-mediated vasodilation in rat cremaster arteries
Ramesh C Mishra, Mohammad M Rahman, Michael J Davis, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 9, 2011
Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3
Vikram G Shakkottai, Maria do Carmo Costa, James M Dell'Orco, et al.
Journal of Medicinal Chemistry
|
April 16, 2004
Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity
Jonathan B Baell, Robert W Gable, Andrew J Harvey, et al.
Molecular Pharmacology
|
October 29, 2008
Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure
Ananthakrishnan Sankaranarayanan, Girija Raman, Christoph Busch, et al.
Frontiers in Pharmacology
|
October 17, 2019
The Trials and Tribulations of Structure Assisted Design of K<sub>Ca</sub> Channel Activators
Heesung Shim, Brandon M Brown, Latika Singh, et al.
Page
of 23
Search research articles
Search
Showing results (91-100 of 222) with videos related to
Sort By:
Page
of 23
Pharmacological Reviews
|
March 8, 2017
International Union of Basic and Clinical Pharmacology. C. Nomenclature and Properties of Calcium-Activated and Sodium-Activated Potassium Channels
Leonard K Kaczmarek, Richard W Aldrich, K George Chandy, et al.
Molecular Pharmacology
|
May 25, 2004
Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators
Julia Vennekamp, Heike Wulff, Christine Beeton, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 23, 2012
Structure-activity relationship exploration of Kv1.3 blockers based on diphenoxylate
William Nguyen, Brittany L Howard, David P Jenkins, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 19, 2010
Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis
Lie Di, Shekhar Srivastava, Olga Zhdanova, et al.
Frontiers in Pharmacology
|
June 12, 2012
Triarylmethanes, a new class of cx50 inhibitors
Silke B Bodendiek, Clio Rubinos, Maria Pilar Trelles, et al.
Physiological Reports
|
May 15, 2018
Alpha<sub>1</sub> -adrenergic stimulation selectively enhances endothelium-mediated vasodilation in rat cremaster arteries
Ramesh C Mishra, Mohammad M Rahman, Michael J Davis, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 9, 2011
Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3
Vikram G Shakkottai, Maria do Carmo Costa, James M Dell'Orco, et al.
Journal of Medicinal Chemistry
|
April 16, 2004
Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity
Jonathan B Baell, Robert W Gable, Andrew J Harvey, et al.
Molecular Pharmacology
|
October 29, 2008
Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure
Ananthakrishnan Sankaranarayanan, Girija Raman, Christoph Busch, et al.
Frontiers in Pharmacology
|
October 17, 2019
The Trials and Tribulations of Structure Assisted Design of K<sub>Ca</sub> Channel Activators
Heesung Shim, Brandon M Brown, Latika Singh, et al.
Page
of 23